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Available online 11 October 2016Introduction: The worldwide obesity epidemic is creating new challenges for surgeons involved in breast
reconstruction. This systematic review aims to summarise the research available in order to determine
the surgical and medical complications, the duration of surgery and post-operative hospital stay and
the likelihood of reoperation in each of the different techniques of breast reconstruction in women with
obesity. To our knowledge, no systematic review is currently available that assesses the impact of obesity
on breast reconstruction outcomes.
Methods and analysis: Electronic searches will be conducted on Cochrane, PUBMED and EMBASE, from
their inception to 1 June 2016. All cohort studies, case series, randomised controlled trials, and case-
control studies on women undergoing breast reconstruction post mastectomy for oncological reasons
will be included. Articles must mention at least one of the primary outcomes of interest. Full exclusion
and inclusion criteria are described within this protocol. Primary and secondary outcomes are described
within this protocol. The search strategy, described within this protocol, aims to identify all articles on
‘‘obesity and breast reconstruction.”
Discussion: This paper outlines the study protocol for a systematic literature review that will identify and
summarise currently available evidence on the effectiveness and complications of breast reconstructive
procedures in women with a BMI >30 kg/m2. This review aims to provide an overview of the evidence in
order to create a guide for healthcare professionals involved in the breast reconstruction of obese women.
Dissemination: This review will be published in a peer-reviewed journal and will be presented at various
national and international conferences.
 2016 The Authors. Published by Elsevier Ltd on behalf of Surgical Associates Ltd. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Obesity is acquiring global epidemic proportions and is impos-
ing a significant public health concern. The most recent data by the
World Health Organization, which defines obesity as having a body
mass index (BMI) of P30 kg/m2, states that 13% of the world’s
adult population is obese [1].
More specifically, obesity is on the rise for women, with 40% of
the global female population being overweight and 15% obese [1].
Additionally, breast cancer is on the rise, accounting for approxi-
mately 30% of all newly reported cancer cases [2]. Consequently,
it is likely that the proportion of women seeking breast reconstruc-
tion in the obese population is increasing [3], and it is imperativeto evaluate the efficacy and possible complications of the recon-
structive techniques currently available.
Studies have shown that obese women, in comparison to those
with normal BMI, have an increased risk for perioperative compli-
cations in various surgical procedures, including breast reconstruc-
tion [4]. Consequently, these patients create unique challenges to
healthcare professionals as they have a higher risk of perioperative
medical complications, including pulmonary embolism, myocar-
dial infarction, and sepsis [5].
Furthermore, research suggests that this population is more
likely to experience complications in both prosthetic and autolo-
gous breast reconstruction, with obese women demonstrating
complication rates of 25% in comparison to 14% in non-obese indi-
viduals [6]. More specifically, research has found a greater occur-
rence of wound complications in breast reconstruction in obese
patients. The same study found that obese patients have a 5.3%
2 A. Panayi et al. / International Journal of Surgery Protocols 2 (2016) 1–4higher risk of reoperation within 30 days compared with nonobese
patients [7].
The risk of failure of prosthetic breast reconstruction in obese
patients has been found to be as high as 20–25% [8]. Obesity has
been shown to be a positive predictor for skin necrosis and infec-
tion, which are the two major complications associated with pros-
thetic breast reconstruction and which often lead to reoperation
[9]. In addition to the increased likelihood of infection and flap
necrosis, there is also a positive correlation between obesity and
the occurrence of seroma [10,11], with one study finding that a sin-
gle unit increase in BMI was associated with a 9.23% increase in the
odds of seroma [12]. Early prosthesis loss, which is an infrequent
but very serious complication of breast reconstruction, has also
been correlated to obesity [13].
A higher rate of loss has been correlated between obese patients
and tissue expander breast reconstruction [14]. In addition, the
pedicled transverse rectus abdominis myocutaneous (TRAM) flap
has been reported as having significantly higher rates of flap com-
plications in obese patients [15]. In addition, obesity should be
considered a relative contraindication in abdominal donor site
autologous reconstruction, according to research [16].
Although it is widely accepted that a raised BMI increases the
risk of complications in breast reconstruction, a detailed compar-
ison of the risk associated with each of the numerous reconstruc-
tive options available has been elusive [17]. By improving our
understanding of the effect of weight on surgical complications
and outcomes breast reconstruction healthcare professionals will
be able to identify the best strategy for each patient in order to
minimise adverse effects.
Therefore, given the rising prevalence of obesity among breast
reconstruction patients, this review seeks to analyse and sum-
marise the current literature to provide a better understanding of
the risks related to breast reconstruction among women with obe-
sity. The findings from such a review aim to provide a guide for the
treatment of such women. Here we report our protocol for the sys-
tematic review.Objective
To perform a comprehensive systematic review of the current
literature in order to assess the peri-operative outcomes in obese
women who have undergone breast reconstruction.
The outcome measures of interest are:
1. Surgical morbidity.
2. Medical complications.
3. Length of postoperative hospital stay.
4. Reoperation.
5. Patient satisfaction.
Methodology
This systematic review will be conducted in line with the rec-
ommendations outlined in the Cochrane Handbook for Systematic
Reviews of Interventions version 5.1.0 [18]. It will be reported
according to the Preferred Reporting Items for Systematic Reviews
and meta-Analyses (PRISMA) statement [19].Criteria for selecting studies
The following inclusion criteria were selected to address the
research question stated.Types of studies/material
Studies to be included are cohort studies, case series, ran-
domised controlled trials, and case-control studies. Included arti-
cles must mention at least one of the primary outcomes of
interest. Articles to be excluded are unpublished trials and reports,
studies that fail to provide an indication for the procedure, case
reports, duplicate studies, cost-effectiveness studies, and studies
that do not provide the original data such systematic reviews,
meta-analyses, editorials, discussions, commentaries and letters.
Types of participants
Female patients with a BMI >30 kg/m2 undergoing immediate
or delayed breast reconstruction following a mastectomy for the
treatment of breast cancer. Transgender cases will not be included.
Types of interventions
This review will consider the following surgical interventions:
prosthetic implants, including tissue expander and acellular der-
mal matrix use, and autologous fat grafting, including pedicled,
free and muscle sparing TRAM flaps, latissimus dorsi myocuta-
neous (LDM) flaps, deep inferior epigastric perforators (DIEP) flaps,
and superficial inferior epigastric artery (SIEA) flap. The surgeries
included should have been performed solely for the purpose of
reconstruction following oncological surgery. Traumatic breast
defects (such as amputations, trauma or burns), as well as cosmetic
procedures, will be excluded.
Types of comparator
Studies with a comparator will not be excluded from this
review. There are no restrictions on the type of comparator and
could include overweight women as well as women with normal
BMI.
Outcomes
There are five distinct outcomes of interest:
Primary outcomes:
1. Surgical morbidity: in terms of intra- and postoperative compli-
cations, including local wound infection or disruption, palpable
nodules, fat necrosis, seroma and prosthesis/flap failure.
2. Medical complications: including deep vein thrombosis, pul-
monary embolism, acute renal failure, myocardial infarction
and sepsis. The validated Clavien–Dindo classification will be
used for grading of postoperative complications.
3. Length of postoperative hospital stay.
4. Reoperation: number of sessions required to achieve a satisfac-
tory outcome.
5. Patient satisfaction.
Secondary outcomes:
1. To determine optimal methods of breast reconstruction.
2. To help refine patient selection for each procedure.
Search methodology for identification of studies
Electronic searches
The following electronic databases will be screened from their
inception to 1 June 2016: Cochrane, PUBMED and EMBASE.
Search terms and keywords
The databases will be searched using the following keywords:
obesity, morbid obesity, Body Mass Index, BMI, weight, quetelet
index, breast reconstruction, prosthetic breast implant, breast
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Fig. 1. Number of articles published per year and indexed by Pubmed under the
search term ‘‘breast reconstruction and obesity.”
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myocutaneous flap, pedicled TRAM flap, free muscle-sparing TRAM
flap, latissimus dorsi myocutaneous flap, deep inferior epigastric
perforators flap, superficial inferior epigastric artery flap, breast
tissue expander. The language will be restricted to English and
the search format will be tailored to the appropriate syntax of each
database.
Identification and selection of articles
The article selection process will be a two-stage process com-
pleted by two independent reviewers. The citation, title and
abstracts of studies identified through the electronic search will
be tabulated into Microsoft Excel and duplicates will be removed.
First, the titles and abstracts will be scanned for relevance. The full
manuscript of articles that have passed through this selection stage
will then be assessed for eligibility. If the two independent review-
ers disagree on inclusion or exclusion of a title/abstract/paper, a
third reviewer will be consulted to achieve consensus. The inclu-
sion and exclusion criteria used to select the studies for this review
are listed in Table 1. Once the inclusion list is finalised, data extrac-
tion will take place.
Data extraction and management
Data extraction will be conducted by two independent review-
ers with discrepancies resolved by discussion between the twoTable 1
Inclusion and exclusion criteria for study selection.
Inclusion criteria
Cohort studies, case series, randomised controlled trials, and case–control studies
Prospective and retrospective studies
Patients who underwent breast reconstruction following a mastectomy for the treatm
Female patients of any age
Patients that underwent prosthetic implant (saline or silicone) or autologous tissue fla
flap, SIEA flap) breast reconstruction
At least one primary outcome reported
Exclusion criteria
Unpublished trials and reports, case reports, duplicate studies, cost-effectiveness stud
meta-analyses, editorials, discussions, commentaries and letters
Non–English language studies
Studies conducted on cadavers or animals
Studies conducted on male or transgender patients
Studies with no data on complications
Studies that used combined techniques
Studies that do not indicate a reason for the procedure
Patients who underwent breast reconstruction for aesthetic purposes or for traumati
Studies that did not specify the number of patientsreviewers. Data will be extracted to pre-established extraction
forms, formatted in a Microsoft Excel database, where relevant
data for each study will be collated.
The following data will be extracted.
- Reference (lead author, year of publication, country)
- Type of study
- LoE (Oxford Centre for Evidence-based Medicine)
- Reconstructive technique
- Number of patients
- Mean or median BMI of participants
- Mean or median age of participants
- Previous breast surgery
- Number of previous breast reconstruction surgery
- Time interval between previous breast surgery and reconstruc-
tive surgery
- Duration of surgery
- Length of postoperative hospital stay
- Follow-up duration
- Loss to follow-up expressed as a percentage
- Surgical and medical complications as outlined above
Data synthesis and statistical analysis
The outcomes of interest, as defined above, will be tabulated
and shown in descriptive or numeric form as appropriate and
summarised
Dissemination
The review can be regarded as a valuable working document for
healthcare professionals who need to be aware of the outcomes of
breast reconstruction when caring for obese women. It will be pub-
lished in a peer-reviewed journal in the English language and will
be presented at various national and international surgical
conferences.
Conclusion
This systematic review aims to summarise available evidence in
order to evaluate the effectiveness, complications and outcomes of
the various breast reconstruction techniques in women with a BMI
greater than 30 kg/m2. It will explore if, and how, previous breast
surgery affects the outcome of breast reconstruction. It will also
explore if, and how, obesity impacts length of surgery and hospital
stay and whether it increases the likelihood of reoperation. Overallent of breast cancer
p (TRAM flap, pedicled TRAM flap, free muscle-sparing TRAM flap, LDM flap, DIEP
ies, and studies that do not provide the original data such systematic reviews,
c breast defects
4 A. Panayi et al. / International Journal of Surgery Protocols 2 (2016) 1–4the review should be useful in guiding healthcare practitioners to
the select the most appropriate form of surgery for obese women
seeking breast reconstruction. (Fig. 1)
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.isjp.2016.10.001.
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